28/09/2026
In four short weeks, on 23 October, we will come together for Patient Community Day, supported by our 64 partners worldwide.
We are grateful for their support. Patient Community Day is the inspiring conclusion to , where the latest research highlights are shared directly with those most impacted by them: people living with MS and related neurological conditions.
Our Supporting Partner network includes patient organisations, research and clinical centres, advocacy groups and other organisations supporting people affected by MS, NMOSD and MOGAD.
Together, they connect Patient Community Day with communities around the world, helping the latest research and information reach the people it matters to most.
๐ Share this post with your community and invite them to take part: https://bit.ly/3T3BQ8U
โญ ๐๐ฎ๐ซ ๐๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ญ๐ง๐๐ซ๐ฌ:
Multiple Sclerosis International Federation (MSIF), National Multiple Sclerosis Society, European Multiple Sclerosis Platform (EMSP), European Charcot Foundation, MStranslate, MS Canada, Destination Toronto, RealTalk MS,
Multiple Sclerosis Association of America (MSAA), Manitoba Multiple Sclerosis Research Centre, The Neuro (Montreal Neurological Institute-Hospital), Esclerosis Mรบltiple Espaรฑa, The Sumaira Foundation EU, Multiple Sclerosis Trust, Shift.ms, Cambridge Clinical Multiple Sclerosis Research,
MS Australia, Deutsche Multiple Sklerose Gesellschaft, Bundesverband e.V.(DMSG), UK MS Register, Multiple Sclerosis Ireland, Asociaciรณn Espaรฑola Nmosd: NMO y MOGAD ,
Israel MS Society, Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Hungarian Neuroimmunology Society, Le rรฉseau ALSACEP, The Multiple Sclerosis Fashionista, Kultivate,CEMCAT, MENACTRIMS,European Brain Council, Swedish MS Association, We Are ILL and The Barlo MS Centre
๐ ๐๐๐ ๐ฆ๐จ๐ซ๐ ๐จ๐ ๐จ๐ฎ๐ซ ๐๐ฎ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ญ๐ง๐๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐จ๐ฆ๐ฆ๐๐ง๐ญ๐ฌ ๐๐๐ฅ๐จ๐ฐ.